Indian drugs are cheaper says govt

NEW DELHI

Central govt. defended its decision to end the custom duty exemption for import of 76 LIFE SAVING DRUGS including those for the treating cancer, AIDS, Hemophilia. Government has said Indian manufacturers are already selling most of these drugs at cheaper prices.

Govt. also claimed there will only be marginal increases in prices of these imported drugs due to exemption withdrawl. Health ministry official also said ”In case of 95% of these drugs the custom duty is only 2.5%,so if there is a increase it would be very marginal .While  the medicine directly impact the treatment of crucial health problems like HIV ,AIDS and HAEMOPHILLIA, the official also said majority of such patients are treated by Govt. hospitals. The list of 76 medicines also contains pharmaceuticals ingredients.

A notification issued by CENTRAL BOARD OF EXCISE AND CUSTOMS had withdrawn the customs duty exemption on the impact of 76 drugs. They are used in treatment of diseases like PARKINSONS DISEASE, BONE DISEASES,KIDNEY STONES,BACTERIAL INFECTION, ARTHRITIS,LUPUS .

  • Related Posts

    Lupin launches Ipratropium Bromide nasal spray in US

    Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal…

    12 dead, 13 workers rescued as reactor blast rips through pharma unit near Hyderabad

    Bodies of 12 workers were brought out and 13 others were rescued from under the debris after a blast in a reactor unit at Sigachi Industries Pvt. Ltd. in the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end